Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone

Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75; doi:10.1080/13625180902916020

This article reports on results of a clinical trial evaluating two routes of misoprostol administration following mifepristone for early medical abortion. For gestations through 56 days since last menstrual period 400mcg of oral misoprostol performed better than a 400mcg sublingual dose when following 200mg mifepristone although not significantly so.